Europe Bioprocess Validation Market Size & Outlook

The bioprocess validation market in Europe is expected to reach a projected revenue of US$ 228.6 million by 2030. A compound annual growth rate of 8.4% is expected of Europe bioprocess validation market from 2024 to 2030.
Revenue, 2023 (US$M)
$129.6
Forecast, 2030 (US$M)
$228.6
CAGR, 2024 - 2030
8.4%
Report Coverage
Europe

Europe bioprocess validation market, 2018-2030 (US$M)

Europe

Europe bioprocess validation market highlights

  • The Europe bioprocess validation market generated a revenue of USD 129.6 million in 2023.
  • The market is expected to grow at a CAGR of 8.4% from 2024 to 2030.
  • In terms of segment, bioprocess residuals testing was the largest revenue generating testing type in 2023.
  • Extractables & Leachables Testing is the most lucrative testing type segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.


Europe data book summary

Market revenue in 2023USD 129.6 million
Market revenue in 2030USD 228.6 million
Growth rate8.4% (CAGR from 2023 to 2030)
Largest segmentBioprocess residuals testing
Fastest growing segmentExtractables & Leachables Testing
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationExtractables & Leachables Testing, Bioprocess Residuals Testing, Viral Clearance Testing, Filtration & Fermentation Systems Testing
Key market players worldwideEurofins Scientific SE, Sartorius AG, Merck KGaA, Thermo Fisher Scientific Inc, Lonza Group Ltd, Danaher Corp, Charles River Laboratories International Inc, SGS AG, Labcorp Holdings Inc, Cobetter Filtration


Other key industry trends

  • In terms of revenue, Europe region accounted for 28.3% of the global bioprocess validation market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 204.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Bioprocess Validation Market Companies

Name Profile # Employees HQ Website

Europe bioprocess validation market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bioprocess validation market will help companies and investors design strategic landscapes.


Bioprocess residuals testing was the largest segment with a revenue share of 29.09% in 2023. Horizon Databook has segmented the Europe bioprocess validation market based on extractables & leachables testing, bioprocess residuals testing, viral clearance testing, filtration & fermentation systems testing covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Europe bioprocess validation market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe bioprocess validation market databook

  • Our clientele includes a mix of bioprocess validation market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe bioprocess validation market , including forecasts for subscribers. This continent databook contains high-level insights into Europe bioprocess validation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe bioprocess validation market size, by country, 2018-2030 (US$M)

Europe Bioprocess Validation Market Outlook Share, 2023 & 2030 (US$M)

Europe bioprocess validation market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more